Clinical Trial Update: A Study of Fotemustine(FTM) Vs FTM and Ipilimumab (IPI) or IPI and Nivolumab in Melanoma Brain Metastasis [Phase 3]

View source ↗

Summary

A Phase 3 study comparing fotemustine alone versus combinations with ipilimumab or ipilimumab plus nivolumab for melanoma with brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma with Brain Metastases

Drugs mentioned

• Fotemustine (fotemustine)
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Italian Network for Tumor Biotherapy Foundation | Conditions: Brain Metastases | Phase 3 | Status: UNKNOWN